Psoas muscle CT radiomics-based machine learning models to predict response to infliximab in patients with Crohn's disease.
Journal:
Annals of medicine
Published Date:
Jul 5, 2025
Abstract
BACKGROUND: Crohn's disease (CD) is a chronic inflammatory bowel disease, with infliximab (IFX) commonly used for treatment. However, no clinically applicable model currently exists to predict the response of patients with CD to IFX therapy. Given the strong association between sarcopenia and IFX treatment outcomes, this study developed computerized tomography radiomics-based machine learning (ML) models, utilizing psoas muscle volume as a proxy for skeletal muscle mass, to predict the response of patients with CD to IFX therapy.